Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

471804 (HBC)

YHD - YHD Delayed Price. Currency in USD
Add to watchlist
- (-)
At close: 06:07PM EDT
Advertisement
Full screen
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • GlobeNewswire

    Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2022

    The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 29 April 2022 at 13:00 CET. Please find the notice to the Annual General Meeting attached and relevant documents referred to in the notice are made available on www.hofsethbiocare.com. For further information, please contact: Jon Olav Ødegård, CFO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer

  • GlobeNewswire

    Hofseth Biocare ASA: HBC ANNUAL REPORT 2021

    Today, 25 March 2022, the Board of Directors of Hofseth BioCare ASA approved the Annual Report for 2021. Please find the Annual Report 2021 and ESG Report attached. For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 93632966E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new drug leads. Research is ongoing to identify the individual elements within its ingredien

Advertisement
Advertisement